Preclinical activity profile of α-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy

被引:39
作者
Citraro, Rita [1 ]
Scicchitano, Francesca [1 ]
De Fazio, Salvatore [1 ]
Raggio, Riccardo [2 ]
Mainardi, Paolo [3 ]
Perucca, Emilio [4 ,5 ]
De Sarro, Giovambattista [1 ]
Russo, Emilio [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Sch Med, Chair Pharmacol, Dept Expt & Clin Med, I-88100 Catanzaro, Italy
[2] Univ Genoa, Dept Pharmaceut Sci, Genoa, Italy
[3] Univ Genoa, Dept Neurosci Ophthalmol & Genet, Genoa, Italy
[4] Univ Pavia, Clin Pharmacol Unit, I-27100 Pavia, Italy
[5] Inst Neurol IRCCS C Mondino Fdn, Clin Trial Ctr, Pavia, Italy
关键词
Serotonin; ALAC; Audiogenic seizures; Pilocarpine; GEPR; CONVENTIONAL ANTIEPILEPTIC DRUGS; BRAIN-SEROTONIN ACTIVITY; ANTICONVULSANT ACTIVITY; ANIMAL-MODELS; PARA-CHLOROPHENYLALANINE; EXTRACELLULAR LEVELS; AUDIOGENIC-SEIZURES; ABSENCE EPILEPSY; AMINO-ACIDS; RAT MODEL;
D O I
10.1016/j.eplepsyres.2011.02.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: To evaluate the potential anticonvulsant activity of alpha-lactalbumin (ALAC), a whey protein rich in tryptophan (TRP) relative to other large neutral aminoacids (LNAAs), in rodent models of seizures and epilepsy. Methods: The effects of ALAC administered per os were evaluated by standard protocols against audiogenic seizures in Genetic Epilepsy Prone Rats (GEPR-9 rats), maximal electroshock (MES)-induced seizures in rats, pilocarpine-induced seizures in mice, spontaneous chronic seizures in mice exposed to pilocarpine-induced status epilepticus (SE), and absence seizures in WAG/Rij rats. In some models, carbamazepine (CBZ) was included as an active control. Plasma TRP/LNAAs ratios were measured by GC-MS. Results: Single doses of ALAC up to 500 or 6000 mg/kg were devoid of anticonvulsant activity in all models tested. Conversely, 5- and 12-day treatment with ALAC (250-1000 mg/kg/day) in GEPR rats reduced dose-dependently seizure scores and prolonged latency to clonus onset, with full persistence of the effect for up to 12h. ALAC (125-500 mg/kg/day for 15 days) protected against seizures induced by 250 mg/kg pilocarpine, but was less effective against higher pilocarpine doses. Similarly to CBZ, ALAC (125-500 mg/kg/day for 15 days) was also effective against spontaneous seizures in the post-pilocarpine SE model. ALAC (up to 6000 mg/kg/day for 12 days) did not prevent MES-induced seizures, although it reduced the duration of tonic extension at doses between 250 and 1000 mg/kg/day. Absence seizures in WAG/Rij rats were not significantly affected by ALAC. Plasma TRP/LNAAS ratios increased 2- to 3-fold after dosing with ALAC (250 mg/kg/day) for 7 and 14 days, respectively. Conclusions: ALAC exerts significant protective activity against seizures in animal models, the effect being especially prominent against audiogenic seizures in GEPR-9 rats, seizures induced by low-dose pilocarpine in mice, and spontaneous seizures in mice exposed to pilocarpine-induced SE. This action is likely to be mediated by increased availability of TRP in the brain, with a consequent increase in 5-HT mediated transmission. (c) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:60 / 69
页数:10
相关论文
共 79 条
[1]   Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids [J].
Ahmad, S ;
Fowler, LJ ;
Whitton, PS .
EPILEPSY RESEARCH, 2005, 63 (2-3) :141-149
[2]   Successful treatment of epilepsy with serotonin reuptake inhibitors: Proposed mechanism [J].
Albano, C. ;
Cupello, A. ;
Mainardi, P. ;
Scarrone, S. ;
Favale, E. .
NEUROCHEMICAL RESEARCH, 2006, 31 (04) :509-514
[3]  
ALBANO C, 2006, 7 EUR C EP HELS 2 8
[4]  
ALEXANDER GJ, 1976, PSYCHOPHARMACOL COMM, V2, P379
[5]   Serotonin transporter gene variation and refractory mesial temporal epilepsy with hippocampal sclerosis [J].
Andres Kauffman, Marcelo ;
Consalvo, Damian ;
Gonzalez-Moron, Dolores ;
Aguirre, Florencia ;
D'Alessio, Luciana ;
Kochen, Silvia .
EPILEPSY RESEARCH, 2009, 85 (2-3) :231-234
[6]   Serotonin and epilepsy [J].
Bagdy, Gyorgy ;
Kecskemeti, Valeria ;
Riba, Pal ;
Jakus, Rita .
JOURNAL OF NEUROCHEMISTRY, 2007, 100 (04) :857-873
[7]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[8]   Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy [J].
Barton, ME ;
Klein, BD ;
Wolf, HH ;
White, HS .
EPILEPSY RESEARCH, 2001, 47 (03) :217-227
[9]   5-HT2 modulation of AY-9944 induced atypical absence seizures [J].
Bercovici, Eduard ;
Cortez, Miguel A. ;
Snead, O. Carter, III .
NEUROSCIENCE LETTERS, 2007, 418 (01) :13-17
[10]   ANTICONVULSANT COMPOUNDS AND 5-HYDROXYTRYPTAMINE IN RAT BRAIN [J].
BONNYCASTLE, DD ;
GIARMAN, NJ ;
PAASONEN, MK .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1957, 12 (02) :228-231